XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net income $ (470,551) $ 48,272
Depreciation and amortization 376,920 381,854
Amortization of debt discount 61,975 47,025
Change in fair value of warrants (19,606)
Amortization of deferred gain on sale/leaseback (28,486) (26,693)
Provision for losses on accounts receivable (17,781) 1,827
Provision for losses on inventories (35,503) 20,099
Deferred income taxes (133,982) 8,124
Change in assets and liabilities:    
Accounts receivable (465,865) 2,660,360
Inventories (1,995,477) 815,593
Prepaid expenses and other assets 109,567 13,083
Trade payables 1,572,804 (20,172)
Accrued liabilities 127,038 (846,643)
Net cash provided by operating activities (899,341) 3,083,123
Cash flows from investing activities:    
Purchases of property, plant and equipment 63,533 (219,927)
Net cash used in investing activities 63,533 (219,927)
Cash flows from financing activities:    
Change in checks written in excess of bank balance (442,992) (629,530)
Net change in revolving line of credit 2,123,582 (1,835,972)
Repayment of long-term debt (related parties $0 and $2,000) (432,942) (390,788)
Cash paid for deferred financing fees (24,568)
Net cash used in financing activities 1,223,080 (2,856,290)
Effect of exchange rate changes on cash 27,307 12,759
Net decrease in cash and cash equivalents 414,579 19,665
Cash and cash equivalents at beginning of period 181,026 563,043
Cash and cash equivalents at end of period 595,605 582,708
Supplemental disclosure of cash flow information:    
Cash payments for interest 408,001 311,768
Supplemental Disclosure of non-cash investing and financing activity    
Property, Plant & Equipment acquisitions funded by liabilities $ 25,387 $ 63,474